Form 4 for SGRY Surgery Partners, Inc.

Accepted 2026-03-09 00:00:00 ET · period of report 2026-03-05 · accession 0001638833-26-000023 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2026-03-09	2026-03-05	SGRY	Doherty David T	CFO	A - Grant	$14.11	+141.7K	200.0K	+243%	+$2.00M
	2026-03-09	2026-03-06	SGRY	Doherty David T	CFO	S - Sale	$13.84	-14.6K	88.8K	-14%	-$201.7K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2026-03-05	A	A	30,501	$14.11	230,546	D	—	—	(F5) Represents restricted stock awards ("RSAs") granted to the reporting person on March 5, 2026 (the "Grant Date"). The RSAs vest on the second anniversary of the Grant Date.
2	Common	Common Stock	2026-03-06	S	D	14,574	$13.84	88,803	D	—	—	(F1) Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on February 28, 2026 and March 2, 2026. (F2) The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
3	Common	Common Stock	2026-03-05	A	A	56,697	$14.11	145,500	D	—	—	(F3) Represents restricted stock awards ("RSAs") granted to the reporting person on March 5, 2026 (the "Grant Date"). The RSAs vest in three equal annual installments beginning on the first anniversary of the Grant Date.
4	Common	Common Stock	2026-03-05	A	A	54,545	$14.11	200,045	D	—	—	(F4) Represents restricted stock awards ("RSAs") granted to the reporting person on March 5, 2026 (the "Grant Date"). The RSAs vest on the first anniversary of the Grant Date.